Home NDC 69853-0101 ANDEXXA
Product NDC 69853-0101
11-digit product format 698530101
Labeler code 69853
Product ID 69853-0101_66dcac76-655d-4aeb-9111-14adc2c9fd70
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name andexanet alfa
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Portola Pharmaceuticals
Application BLA125586
Marketing category BLA
Marketing start 2018-05-14
Marketing end 2020-10-31
Substance ANDEXANET ALFA
Active strength 100 mg/10mL
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join ANDEXXA ANDEXANET ALFA AstraZeneca Pharmaceuticals LP 2d9d90a6-63e6-46ef-96ff-dd6519ae7b6c 2025-05-23 Boxed warning, Warnings, Adverse reactions Exact identifier application number: BLA125586
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 125586 Andexxa Coagulation Factor Xa (Recombinant), Inactivated-zhzo 351(a) Disc 2026-06-01